title: Alteration of T cell cytokine production in PLPp-139-151-induced EAE in SJL mice by an immunostimulatory CpG oligonucleotide.
abstract: Experimental autoimmune encephalomyelitis (EAE) is--in certain aspects--regarded as an animal model of the human CNS autoimmune disease multiple sclerosis (MS). While in EAE CNS-autoantigen-specific immunity is induced in a defined way, the initial processes leading to CNS autoimmunity in humans are so far unknown. Despite essential restrictions, which exist regarding the interpretation of EAE data towards MS, EAE might be a useful model to study certain basic aspects of CNS autoimmunity. Studies in MS have demonstrated that established autoimmune pathology can be critically influenced by environmental factors, in particular viral and bacterial infections. To investigate this interaction, EAE as an instrument to study CNS autoimmunity under defined conditions appears to be a suitable experimental tool. For this reason, we here investigated the influence of the Toll-like-receptor (TLR) ligand CpG oligonucleotide (CpG) on already established CNS autoimmunity in murine proteolipid protein (PLP)-induced EAE in SJL mice. CpG were found to co-stimulate PLPp-specific IFN-γ production in the peripheral immune system and in the CNS. However, CpG induced Interleukin (IL)-17 production in the inflamed CNS both alone and in combination with additional PLPp stimulation. These findings might indicate a mechanism by which systemic infections and the microbial stimuli associated with them may influence already existing CNS autoimmune pathology.
authors.affiliation: Department of Neurology, Heinrich Heine University, Düsseldorf, Germany.
authors.forename: Vsevolod
authors.initials: V
authors.lastname: Smolianov
authors.forename: Thomas
authors.initials: T
authors.lastname: Dehmel
authors.forename: Patrick
authors.initials: P
authors.lastname: Vollmar
authors.forename: Anne K
authors.initials: AK
authors.lastname: Mausberg
authors.forename: Bernd C
authors.initials: BC
authors.lastname: Kieseier
authors.forename: Bernhard
authors.initials: B
authors.lastname: Hemmer
authors.forename: Hans P
authors.initials: HP
authors.lastname: Hartung
authors.forename: Harald H
authors.initials: HH
authors.lastname: Hofstetter
mesh_terms: D000276:Adjuvants, Immunologic; D019264:Adoptive Transfer; D000818:Animals; D001323:Autoantibodies / Q000276:immunology; D015551:Autoimmunity / Q000276:immunology; D016207:Cytokines / Q000276:immunology*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000139:chemically induced / Q000276:immunology; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000276:immunology; D020381:Interleukin-17 / Q000276:immunology; D007376:Interleukin-2 / Q000276:immunology; D051379:Mice; D018991:Myelin Proteolipid Protein / Q000276:immunology / Q000494:pharmacology*; D009838:Oligodeoxyribonucleotides / Q000276:immunology* / Q000494:pharmacology*; D010446:Peptide Fragments / Q000276:immunology / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D001323:Autoantibodies; C408982:CPG-oligonucleotide; D016207:Cytokines; D020381:Interleukin-17; D007376:Interleukin-2; D018991:Myelin Proteolipid Protein; D009838:Oligodeoxyribonucleotides; D010446:Peptide Fragments; C435023:myelin proteolipid protein (139-151); D007371:Interferon-gamma